Patient Square Capital LP
CIK 0001819257 · MENLO PARK, CA · Quarter end: 2026-06-30 · Filed on: 2026-08-12 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$645.5M
2026 Q2
Positions
23
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
80.1%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
ROIV
ROIVANT SCIENCES LTD
44.0%
RVMD
REVOLUTION MEDICINES INC
8.0%
MIRM
MIRUM PHARMACEUTICALS INC
4.7%
ABVX
ABIVAX SA
4.3%
ONC
BEONE MEDICINES LTD
4.0%
PHVS
PHARVARIS N V
3.6%
ARGX
ARGENX SE
3.3%
UTHR
UNITED THERAPEUTICS CORP DEL
3.1%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.